These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15584126)

  • 1. ACE inhibitors reduce heart-related death in type 2 diabetics.
    Health News; 2004 Oct; 10(10):15. PubMed ID: 15584126
    [No Abstract]   [Full Text] [Related]  

  • 2. [Type 2 diabetes mellitus and coronary heart disease].
    Brändle M; Amann FW; Salomon F
    Schweiz Med Wochenschr; 1999 May; 129(18):700-6. PubMed ID: 10407943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ramipril and new therapeutic possibilities for ACE-inhibitors].
    Vespasiani Gentilucci U; Picardi A
    Clin Ter; 2000; 151(4):307-8. PubMed ID: 11107682
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiotensin converting enzyme inhibitors in the treatment of diabetes].
    Smahelová A
    Vnitr Lek; 2003 Dec; 49(12):948-51. PubMed ID: 15040161
    [No Abstract]   [Full Text] [Related]  

  • 7. ACE giveaway could save lives, money.
    Harv Heart Lett; 2005 Oct; 16(2):6. PubMed ID: 16299905
    [No Abstract]   [Full Text] [Related]  

  • 8. ACE inhibitors and cardiovascular protection in diabetes.
    Donnelly R
    Diabetes Obes Metab; 2004 Nov; 6(6):399-401. PubMed ID: 15479215
    [No Abstract]   [Full Text] [Related]  

  • 9. Perindopril protects diabetics with coronary disease from cardiovascular death and heart attacks.
    Cardiovasc J S Afr; 2004; 15(2):98. PubMed ID: 15148549
    [No Abstract]   [Full Text] [Related]  

  • 10. [ACE inhibitor even prevents diabetes. Sensational HOPE Study].
    MMW Fortschr Med; 1999 Sep; 141(39):6. PubMed ID: 10897977
    [No Abstract]   [Full Text] [Related]  

  • 11. HOPE for all people with diabetes? Heart Outcomes Prevention Evaluation.
    Marshall SM
    Diabet Med; 2000 Sep; 17 Suppl 2():9-10. PubMed ID: 11048826
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
    Epstein BJ; Gums JG
    Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serious cardiovascular outcomes in diabetes: the role of hypoglycemia.
    Yakubovich N; Gerstein HC
    Circulation; 2011 Jan; 123(3):342-8. PubMed ID: 21263007
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacological prevention of late complications of diabetes].
    Jensen TJ; Hilsted JC
    Ugeskr Laeger; 1996 Apr; 158(17):2402-3. PubMed ID: 8685997
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke.
    Schelleman H; Klungel OH; Witteman JC; Breteler MM; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Pharmacogenomics J; 2008 Dec; 8(6):400-7. PubMed ID: 18347611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M
    J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin-system blockade in the prevention of diabetes.
    Ostergren J
    Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S13-21. PubMed ID: 17320999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late diagnosis. Only after myocardial infarction is diabetes discovered].
    MMW Fortschr Med; 2003 Feb; 145(9):56. PubMed ID: 12666536
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is it necessary to systematically treat diabetics with ACE inhibitors?].
    Marre M; Collet C; Stevenin C
    Journ Annu Diabetol Hotel Dieu; 2001; ():185-7. PubMed ID: 11565461
    [No Abstract]   [Full Text] [Related]  

  • 20. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.